Instrinsic Life Sciences was just awarded an NIH Small Business Innovation Research Grant. CEO Mark Westerman, Ph.D. announced that the company received $350,000 for the first phase of assay commercialization activities with potential for $1MM over two years for Phase II activities. Additional information on the prestigious SBIR program is available through the National Institute of Health's website at nih.gov. Southern California's BIOCOM picked up this exciting story as well: